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Department of Internal Medicine I, Regensburg University Hospital, D-93042 Regensburg, GermanySeveral unfortunate errors occurred as detailed below. These er-
rors do not compromise the validity of the results or the integrity
of the conclusion drawn upon them.
The term ‘‘Fig. 1B’’ in the last sentence of section 2.6 ‘‘Enzyme-
linked immunosorbent assay (ELISA)’’ on page 3720 has to be de-
leted. The correct sentence is:
‘‘Concentrations were 3.4 (2.9–3.6) ng/ml and, therefore, less
than 5% of galectin-3 in the supernatants of the monocytes with
17.6 (7.5–43.7) ng/ml accord to serum galectin-3.’’
The blots in Fig. 1C are wrong. The correct Fig. 1C is:The blot in Fig. 1D representing GAPDH is wrong. The correct Fig. 1D
is:
